Evidence map›Paper›PMID 7615639›Full record

ArticleThe Journal of cell biology1995

Identification and characterization of a fibroblast marker: FSP1.

F Strutz, H Okada, C W Lo, T Danoff, R L Carone, J E Tomaszewski, E G Neilson

Abstract read
In one paragraph

Article in The Journal of cell biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 471 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
471citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

471 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

411 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

F StrutzPenn Center for Molecular Studies of Kidney Disease, Department of Medicine, University of Pennsylvania, Philadelphia 19104-6144, USA.
H Okada
C W Lo
T Danoff
R L Carone
J E Tomaszewski
E G Neilson

Funding

Training in Renal ResearchT32DK007006 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HOLZMAN, LAWRENCE B. · 1986 to 2023
$8.5M
SHH INDUCTION OF POST-NATAL HAIR FOLLICLE/HAIR GROWTHR01AR046282 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI LEOPOLD, PHILIP L · 2000 to 2004
$1.4M
IMMUNOLOGIC MECHANISMS IN INTERSTITIAL NEPHRITISR01DK030280 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NEILSON, ERIC G · 1986 to 1990
–
IMMUNOLOGIC MECHANISMS OF INTERSTITIAL NEPHRITISR37DK030280 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NEILSON, ERIC G · 1990 to 1997
–
NIAMS NIH HHS AR-46282NIDDK NIH HHS DK-07006NIDDK NIH HHS DK-30280
6 · The paper itself

Abstract

We performed subtractive and differential hybridization for transcript comparison between murine fibroblasts and isogenic epithelium, and observed only a few novel intracellular genes which were relatively specific for fibroblasts. One such gene encodes a filament-associated, calcium-binding protein, fibroblast-specific protein 1 (FSP1). The promoter/enhancer region driving this gene is active in fibroblasts but not in epithelium, mesangial cells or embryonic endoderm. During development, FSP1 is first detected by in situ hybridization after day 8.5 as a postgastrulation event, and is associated with cells of mesenchymal origin or of fibroblastic phenotype. Polyclonal antiserum raised to recombinant FSP1 protein stained the cytoplasm of fibroblasts, but not epithelium. Only occasional cells stain with specific anti-FSP1 antibodies in normal parenchymal tissue. However, in kidneys fibrosing from persistent inflammation, many fibroblasts could be identified in interstitial sites of collagen deposition and also in tubular epithelium adjacent to the inflammatory process. This pattern of anti-FSP1 staining during tissue fibrosis suggests, as a hypothesis, that fibroblasts in some cases arise, as needed, from the local conversion of epithelium. Consistent with this notion that FSP1 may be involved in the transition from epithelium to fibroblasts are experiments in which the in vitro overexpression of FSP1 cDNA in tubular epithelium is accompanied by conversion to a mesenchymal phenotype, as characterized by a more stellate and elongated fibroblast-like appearance, a reduction in cytokeratin, and new expression of vimentin. Similarly, tubular epithelium submerged in type I collagen gels exhibited the conversion to a fibroblast phenotype which includes de novo expression of FSP1 and vimentin. Use of the FSP1 marker, therefore, should further facilitate both the in vivo studies of fibrogenesis and the mapping of cell fate among fibroblasts.

Indexed as

3T3 CellsAnimalsBiomarkersCalcium-Binding ProteinsCell LineEmbryo, MammalianEpithelial CellsEpitheliumFibroblastsGene ExpressionImmunohistochemistryIn Situ HybridizationMicePhenotypePromoter Regions, GeneticS100 Calcium-Binding Protein A4BiomarkersCalcium-Binding ProteinsS100a4 protein, mouseS100 Calcium-Binding Protein A4S100 Proteins

Identifiers

PMID7615639
PMCPMC2199940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.